The endocrine effects of nicotine and cigarette smoke

Trends in Endocrinology and Metabolism

Volumn 23, Issue 7, 2012, Pages 334-342

  Tweed, Jesse Oliver ^a   Hsia, Stanley H ^a   Lutfy, Kabirullah ^a,b   Friedman, Theodore C ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Addiction; Cigarettes; Hormones; Hypogonadism; Nicotine; Pituitary

Indexed keywords

CIGARETTE SMOKE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; ENDORPHIN; ESTRADIOL; FOLLITROPIN; GHRELIN; GONADORELIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; INSULIN; LEPTIN; LIOTHYRONINE; LIPID; LUTEINIZING HORMONE; NICOTINE; OPIATE; OREXIN; PROLACTIN; TESTOSTERONE; THYROTROPIN; THYROXINE; VASOPRESSIN;

CHILDHOOD OBESITY; CIGARETTE SMOKING; CLINICAL EVALUATION; COGNITION; DIABETES MELLITUS; ENDOCRINE DISEASE; ENDOCRINE OPHTHALMOPATHY; FEMALE INFERTILITY; GLUCOSE HOMEOSTASIS; HIP FRACTURE; HORMONE RELEASE; HUMAN; HYPERTHYROIDISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IMMUNE SYSTEM; INSULIN RESISTANCE; MALE INFERTILITY; MEDICAL LITERATURE; MEDICAL RECORD REVIEW; METABOLIC REGULATION; NONHUMAN; OBESITY; OSTEOPOROSIS; PASSIVE SMOKING; PRENATAL EXPOSURE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SMOKING CESSATION; TOBACCO;

ANIMALS; ENDOCRINE SYSTEM DISEASES; HUMANS; HYPOGONADISM; NICOTINE; PITUITARY GLAND; SMOKING;

EID: 84863105681     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2012.03.006     Document Type: Review

References (117)

1. Garrett B.E., et al. Cigarette smoking - United States, 1965-2008. MMWR Surveill. Summ. 2011, 60(Suppl.):109-113.
2. (2010) Vital signs: nonsmokers' exposure to secondhand smoke - United States, 1999-2008. MMWR Morb. Mortal. Wkly. Rep. 59, 1141-1146.
3. Substance Abuse and Mental Health Services Administration: Office of Applied Studies (2008) Results from the 2007 National Survey on Drug Use and Health: National Findings (NSDUH Series H-34, DHHS Publication No. SMA 08-4343).
4. Center for Disease Control and Prevention Cigarette smoking among adults - United States 2007. MMWR 2008, 57:1221-1226.
5. Centers for Disease Control and Prevention Vital signs: current cigarette smoking among adults aged > or = 18 years - United States, 2009. Morb. Mortal. Wkly. Rep. 2010, 59:1135-1140.
6. Xue Y., et al. Venous plasma nicotine correlates of hormonal effects of tobacco smoking. Pharmacol. Biochem. Behav. 2010, 95:209-215.
7. Shaw D., al'Absi M. Blunted opiate modulation of prolactin response in smoking men and women. Pharmacol. Biochem. Behav. 2010, 95:1-5.
8. Fuxe K., et al. Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical implications. Psychoneuroendocrinology 1989, 14:19-41.
9. Asvold B.O., et al. Association of serum TSH with high body mass differs between smokers and never-smokers. J. Clin. Endocrinol. Metab. 2009, 94:5023-5027.
10. Soldin O.P., et al. Thyroid hormone levels associated with active and passive cigarette smoking. Thyroid 2009, 19:817-823.
11. Jorde R., Sundsfjord J. Serum TSH levels in smokers and non-smokers. The 5th Tromso study. Exp. Clin. Endocrinol. Diabetes 2006, 114:343-347.
12. Pedersen I.B., et al. Smoking is negatively associated with the presence of thyroglobulin autoantibody and to a lesser degree with thyroid peroxidase autoantibody in serum: a population study. Eur. J. Endocrinol. 2008, 158:367-373.
13. Effraimidis G., et al. Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study. Eur. J. Endocrinol. 2011, 164:107-113.
14. Effraimidis G., et al. Discontinuation of smoking increases the risk for developing thyroid peroxidase antibodies and/or thyroglobulin antibodies: a prospective study. J. Clin. Endocrinol. Metab. 2009, 94:1324-1328.
15. Bahn R.S. Graves' ophthalmopathy. N. Engl. J. Med. 2010, 362:726-738.
16. Cawood T.J., et al. Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link. J. Clin. Endocrinol. Metab. 2007, 92:59-64.
17. Matta S.G., et al. Nicotine elevates rat plasma ACTH by a central mechanism. J. Pharmacol. Exp. Ther. 1987, 243:217-226.
18. Seyler L.E., et al. The effects of smoking on ACTH and cortisol secretion. Life Sci. 1984, 34:57-65.
19. Rohleder N., Kirschbaum C. The hypothalamic-pituitary-adrenal (HPA) axis in habitual smokers. Int. J. Psychophysiol. 2006, 59:236-243.
20. McEwen A., et al. Motives for smoking and their correlates in clients attending Stop Smoking treatment services. Nicotine Tob. Res. 2008, 10:843-850.
21. Grunberg N.E., Shafer S.T. Stress, smoking, and 9/11/01. Psychiatry 2005, 68:311-315.
22. McKee S.A., et al. Stress decreases the ability to resist smoking and potentiates smoking intensity and reward. J. Psychopharmacol. 2011, 25:490-502.
23. Public Health Service How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General 2010, Department of Health and Human Services, Public Health Service, Office of the Surgeon General.
24. Childs E., de Wit H. Effects of acute psychosocial stress on cigarette craving and smoking. Nicotine Tob. Res. 2010, 12:449-453.
25. Paolini M., De Biasi M. Mechanistic insights into nicotine withdrawal. Biochem. Pharmacol. 2011, 82:996-1007.
26. Shiffman S. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial. Clin. Ther. 2008, 30:1461-1475.
27. Hajek P., et al. The effect of stopping smoking on perceived stress levels. Addiction 2010, 105:1466-1471.
28. Practice Committee of American Society for Reproductive Medicine Smoking and infertility. Fertil. Steril. 2008, 90:S254-S259.
29. Gaur D.S., et al. Alcohol intake and cigarette smoking: impact of two major lifestyle factors on male fertility. Indian J. Pathol. Microbiol. 2010, 53:35-40.
30. Farhi J., Orvieto R. Influence of smoking on outcome of COH and IUI in subfertile couples. J. Assist. Reprod. Genet. 2009, 26:421-424.
31. Halmenschlager G., et al. Evaluation of the effects of cigarette smoking on testosterone levels in adult men. J. Sex Med. 2009, 6:1763-1772.
32. Svartberg J., Jorde R. Endogenous testosterone levels and smoking in men. The fifth Tromso study. Int. J. Androl. 2007, 30:137-143.
33. Wu F.C., et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J. Clin. Endocrinol. Metab. 2008, 93:2737-2745.
34. Wu C., et al. The association of smoking and erectile dysfunction: results from the Fangchenggang Area Male Health and Examination Survey (FAMHES). J. Androl. 2012, 33:59-65.
35. Brand J.S., et al. Cigarette smoking and endogenous sex hormones in postmenopausal women. J. Clin. Endocrinol. Metab. 2011, 96:3184-3192.
36. Varvarigou A.A., et al. Effect of maternal smoking on cord blood estriol, placental lactogen, chorionic gonadotropin, FSH, LH, and cortisol. J. Perinat. Med. 2009, 37:364-369.
37. Villalbí J.R., et al. Maternal smoking, social class and outcomes of pregnancy. Paediatr. Perinat. Epidemiol. 2007, 21:441-447.
38. Pringle P.J., et al. The influence of cigarette smoking on antenatal growth, birth size, and the insulin-like growth factor axis. J. Clin. Endocrinol. Metab. 2005, 90:2556-2562.
39. Clifton V.L., et al. Effect of maternal asthma, inhaled glucocorticoids and cigarette use during pregnancy on the newborn insulin-like growth factor axis. Growth Horm. IGF Res. 2010, 20:39-48.
40. McKlveen J.M., et al. Sexually diergic, dose-dependent hypothalamic-pituitary-adrenal axis responses to nicotine in a dynamic in vitro perfusion system. J. Pharmacol. Toxicol. Methods 2010, 61:311-318.
41. Chiodera P., et al. Gamma-aminobutyric acid mediation of the inhibitory effect of endogenous opioids on the arginine vasopressin and oxytocin responses to nicotine from cigarette smoking. Metabolism 1993, 42:762-765.
42. Chiodera P., et al. Abnormal effect of cigarette smoking on pituitary hormone secretions in insulin-dependent diabetes mellitus. Clin. Endocrinol. 1997, 46:351-357.
43. Nakamoto T., et al. Cigarette smoke extract enhances oxytocin-induced rhythmic contractions of rat and human preterm myometrium. Reproduction 2006, 132:343-353.
44. Dimai H.P., Chandran M. Official Positions for FRAX(R) clinical regarding smoking from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(R). J. Clin. Densitom. 2011, 14:190-193.
45. Jenkins M.R., Denison A.V. Smoking status as a predictor of hip fracture risk in postmenopausal women of northwest Texas. Prev. Chronic Dis. 2008, 5:A09.
46. Need A.G., et al. Relationships between intestinal calcium absorption, serum vitamin D metabolites and smoking in postmenopausal women. Osteoporos. Int. 2002, 13:83-88.
47. Jorde R., et al. Serum parathyroid hormone (PTH) levels in smokers and non-smokers. The fifth Tromso study. Eur. J. Endocrinol. 2005, 152:39-45.
48. Rapuri P.B., et al. Smoking and bone metabolism in elderly women. Bone 2000, 27:429-436.
49. Bjarnason N.H., et al. The influence of smoking on bone loss and response to nasal estradiol. Climacteric 2009, 12:59-65.
50. Audrain-McGovern J., Benowitz N.L. Cigarette smoking, nicotine, and body weight. Clin. Pharmacol. Ther. 2011, 90:164-168.
51. Mozaffarian D., et al. Changes in diet and lifestyle and long-term weight gain in women and men. N. Engl. J. Med. 2011, 364:2392-2404.
52. Chiolero A., et al. Association of cigarettes smoked daily with obesity in a general adult population. Obesity (Silver Spring) 2007, 15:1311-1318.
53. Watari M., et al. A longitudinal study of the influence of smoking on the onset of obesity at a telecommunications company in Japan. Prev. Med. 2006, 43:107-112.
54. Chiolero A., et al. Clustering of risk behaviors with cigarette consumption: A population-based survey. Prev. Med. 2006, 42:348-353.
55. Mineur Y.S., et al. Nicotine decreases food intake through activation of POMC neurons. Science 2011, 332:1330-1332.
56. Huang H., et al. Nicotine excites hypothalamic arcuate anorexigenic proopiomelanocortin neurons and orexigenic neuropeptide Y neurons: similarities and differences. J. Neurophysiol. 2011, 106:1191-1202.
57. Chen H., et al. Detrimental metabolic effects of combining long-term cigarette smoke exposure and high-fat diet in mice. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E1564-E1571.
58. Chen H., et al. Regulation of hypothalamic NPY by diet and smoking. Peptides 2007, 28:384-389.
59. Bouros D., et al. Smoking acutely increases plasma ghrelin concentrations. Clin. Chem. 2006, 52:777-778.
60. Kokkinos A., et al. Differentiation in the short- and long-term effects of smoking on plasma total ghrelin concentrations between male nonsmokers and habitual smokers. Metabolism 2007, 56:523-527.
61. Lee H., et al. Increased leptin and decreased ghrelin level after smoking cessation. Neurosci. Lett. 2006, 409:47-51.
62. Al Mutairi S.S., et al. Effect of smoking habit on circulating adipokines in diabetic and non-diabetic subjects. Ann. Nutr. Metab. 2008, 52:329-334.
63. Hur Y.N., et al. High fat diet altered the mechanism of energy homeostasis induced by nicotine and withdrawal in C57BL/6 mice. Mol. Cells 2010, 30:219-226.
64. Ino T. Maternal smoking during pregnancy and offspring obesity: meta-analysis. Pediatr. Int. 2010, 52:94-99.
65. Oken E., et al. Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis. Int. J. Obesity 2008, 32:201-210.
66. Bruin J.E., et al. Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicol. Sci. 2010, 116:364-374.
67. Koshy G., et al. Dose response association of pregnancy cigarette smoke exposure, childhood stature, overweight and obesity. Eur. J. Public Health 2011, 21:286-291.
68. Somm E., et al. Prenatal nicotine exposure alters early pancreatic islet and adipose tissue development with consequences on the control of body weight and glucose metabolism later in life. Endocrinology 2008, 149:6289-6299.
69. Klesges R.C., et al. Factors associated with participation, attrition, and outcome in a smoking cessation program at the workplace. Health Psychol. 1988, 7:575-589.
70. Spring B., et al. Behavioral intervention to promote smoking cessation and prevent weight gain: a systematic review and meta-analysis. Addiction 2009, 104:1472-1486.
71. Parsons A.C., et al. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst. Rev. 2009, CD006219.
72. Potter B.K., et al. Does a relationship exist between body weight, concerns about weight, and smoking among adolescents? An integration of the literature with an emphasis on gender. Nicotine Tob. Res. 2004, 6:397-425.
73. Chiolero A., et al. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am. J. Clin. Nutr. 2008, 87:801-809.
74. Thiering E., et al. Prenatal and postnatal tobacco smoke exposure and development of insulin resistance in 10 year old children. Int. J. Hyg. Environ. Health 2011, 214:361-368.
75. Inoue K., et al. Early effects of smoking cessation and weight gain on plasma adiponectin levels and insulin resistance. Intern. Med. 2011, 50:707-712.
76. Berlin I. Smoking-induced metabolic disorders: a review. Diabetes Metab. 2008, 34:307-314.
77. Onat A., et al. Prospective epidemiologic evidence of a 'protective' effect of smoking on metabolic syndrome and diabetes among Turkish women - without associated overall health benefit. Atherosclerosis 2007, 193:380-388.
78. Mangubat M., et al. Effect of nicotine on body composition in mice. J. Endocrinol. 2012, 212:317-326.
79. Willi C., et al. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007, 298:2654-2664.
80. Nagaya T., et al. Heavy smoking raises risk for type 2 diabetes mellitus in obese men; but, light smoking reduces the risk in lean men: a follow-up study in Japan. Ann. Epidemiol. 2008, 18:113-118.
81. Hur N.W., et al. Smoking cessation and risk of type 2 diabetes mellitus: Korea Medical Insurance Corporation Study. Eur. J. Cardiovasc. Prev. Rehabil. 2007, 14:244-249.
82. Yeh H.C., et al. Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann. Intern. Med. 2010, 152:10-17.
83. Bruin J.E., et al. Fetal and neonatal nicotine exposure and postnatal glucose homeostasis: identifying critical windows of exposure. J. Endocrinol. 2007, 194:171-178.
84. Maisonneuve P., et al. Impact of smoking on patients with idiopathic chronic pancreatitis. Pancreas 2006, 33:163-168.
85. Wahlberg J., et al. Asthma and allergic symptoms and type 1 diabetes-related autoantibodies in 2.5-yr-old children. Pediatr. Diabetes 2011, 12:604-610.
86. Hirai F.E., et al. Severe hypoglycemia and smoking in a long-term type 1 diabetic population: Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 2007, 30:1437-1441.
87. Bott S., et al. Impact of smoking on the metabolic action of subcutaneous regular insulin in type 2 diabetic patients. Horm. Metab. Res. 2005, 37:445-449.
88. Becker R.H., et al. The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin. Diabetes Care 2006, 29:277-282.
89. Hamabe A., et al. Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. J. Gastroenterol. 2011, 46:769-778.
90. Zein C.O., et al. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J. Hepatol. 2011, 54:753-759.
91. Chiang P.H., et al. Synergistic effect of fatty liver and smoking on metabolic syndrome. World J. Gastroenterol. 2009, 15:5334-5339.
92. Azzalini L., et al. Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. Hepatology 2010, 51:1567-1576.
93. Mangubat M., et al. Nicotine induces oxidative stress and exacerbates high fat diet (HFD)-induced hepatic steatosis in a mouse mode of diet-induced obesity. Endocrine Soc 2011, 93. OR04-OR01.
94. Shin C.S., et al. Nicotine plus a high-fat diet leads to intramyocellular fat deposition in a mouse model of diet-induced obesity. Am. Diabetes Assoc. 2011, 71. 2633-PO.
95. Chelland Campbell S., et al. Smoking and smoking cessation - the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis 2008, 201:225-235.
96. Gepner A.D., et al. Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am. Heart J. 2011, 161:145-151.
97. Conte-Devolx B., et al. Effect of nicotine on in vivo secretion of melanocorticotropic hormones in the rat. Life Sci. 1981, 28:1067-1073.
98. Pomerleau O.F., et al. Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology 1983, 81:61-67.
99. Seyler L.E., et al. Pituitary hormone response to cigarette smoking. Pharmacol. Biochem. Behav. 1986, 24:159-162.
100. Doolittle D.J., et al. The genotoxic potential of nicotine and its major metabolites. Mutat. Res. 1995, 344:95-102.
101. Hukkanen J., et al. Metabolism and disposition kinetics of nicotine. Pharmacol. Rev. 2005, 57:79-115.
102. Yildiz D. Nicotine, its metabolism and an overview of its biological effects. Toxicon 2004, 43:619-632.
103. Fowles J., Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob. Control 2003, 12:424-430.
104. Tuesta L.M., et al. Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. Biochem. Pharmacol. 2011, 82:984-995.
105. Liu R.H., et al. The expression and functional role of nicotinic acetylcholine receptors in rat adipocytes. J. Pharmacol. Exp. Ther. 2004, 310:52-58.
106. Dani J.A., De Biasi M. Cellular mechanisms of nicotine addiction. Pharmacol. Biochem. Behav. 2001, 70:439-446.
107. Benowitz N.L. Nicotine addiction. N. Engl. J. Med. 2010, 362:2295-2303.
108. Mendelson J.H., et al. Effects of smoking successive low- and high-nicotine cigarettes on hypothalamic-pituitary-adrenal axis hormones and mood in men. Neuropsychopharmacology 2008, 33:749-760.
109. Rao U., et al. Contribution of hypothalamic-pituitary-adrenal activity and environmental stress to vulnerability for smoking in adolescents. Neuropsychopharmacology 2009, 34:2721-2732.
110. Buchmann A.F., et al. Cigarette craving increases after a psychosocial stress test and is related to cortisol stress response but not to dependence scores in daily smokers. J. Psychopharmacol. 2010, 24:247-255.
111. Nakanishi N., et al. Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men. Ann. Intern. Med. 2000, 133:183-191.
112. Tatebe J., Morita T. Enhancement of TNF-alpha expression and inhibition of glucose uptake by nicotine in the presence of a free fatty acid in C2C12 skeletal myocytes. Horm. Metab. Res. 2011, 43:11-16.
113. Bergman B.C., et al. Intramuscular lipid metabolism in the insulin resistance of smoking. Diabetes 2009, 58:2220-2227.
114. Kawamoto R., et al. Serum high molecular weight adiponectin is associated with mild renal dysfunction in Japanese adults. J. Atheroscler. Thromb. 2010, 17:1141-1148.
115. Otsuka F., et al. Smoking cessation is associated with increased plasma adiponectin levels in men. J. Cardiol. 2009, 53:219-225.
116. Wang X., et al. Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance. Endocrinology 2011, 152:836-846.
117. Lakhan S.E., Kirchgessner A. Anti-inflammatory effects of nicotine in obesity and ulcerative colitis. J. Transl. Med. 2011, 9:129.